Update on the risk of DVT during air travel - does the economy class syndrome really exist?

Similar documents
Reduced-dosed Rivaroxaban in the long-term prevention of recurrent symptomatic DVT The Einstein-Choice trial

Is the combination of antithrombotics and lowdose anticoagulants worthwhile in PAD The VOYAGER trial

Platelet inhibition PLUS low-dose anticoagulation a new paradigm for all PAD patients?

Understanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal

Flight stockings decrease symptomless deep vein thrombosis in airline passengers on long ights

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

Anticoagulation for prevention of venous thromboembolism

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT

THROMBOSIS RISK FACTOR ASSESSMENT

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Slide 1. Slide 2. Slide 3. Outline of This Presentation

These are guidelines only and can be deviated from if it is thought to be in the patient s best interest.

Low Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders

Mabel Labrada, MD Miami VA Medical Center

Symptomatic Venous Thromboembolism after Total Hip/Knee Replacement: A Population-based Taiwan Study

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge

Scott M. Stevens, MD. Co-Director, Thrombosis Clinic. Associate Professor of Clinical Medicine

General. Recommendations. Guideline Title. Bibliographic Source(s) Guideline Status. Major Recommendations

DVT - initial management NSCCG

Venous Thromboembolic Disease Update

Deep vein thrombosis: diagnosis, prevention and treatment

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community

Superficial Thrombophlebitis Treatment Guideline Review

What evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients?

Management of Post-Thrombotic Syndrome

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban)

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Venous Thromboembolism Prophylaxis

Prevention of Venous Thromboembolism

Venous Thromboembolism Prophylaxis: Checked!

Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital

Oral Anticoagulation Drug Class Prior Authorization Protocol

CHAPTER 2 VENOUS THROMBOEMBOLISM

Date of preparation: September 2014 L.GB d

10/8/2012. Disclosures. Making Sense of AT9: Review of the 2012 ACCP Antithrombotic Guidelines. Goals and Objectives. Outline

Prophylaxis for Hospitalized and Non-Hospitalized Medical Patients

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

Prevention and treatment of venous thromboembolic disease

Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

Duration of anticoagulation

NOAC s across indications

Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN (In Press)

How to prevent blood clots whilst in hospital and after your return home

Prevention and management of venous thromboembolism M. AAPRO

Drug Use Criteria: Direct Oral Anticoagulants

Current issues in the management of Superficial Vein Thrombosis - SVT

Top 5 (or so) Hematology Consults. Tom DeLoughery, MD FACP FAWM. Oregon Health and Sciences University DISCLOSURE

Venous Thrombosis in Asia

1. SCOPE of GUIDELINE:

Spontane und Tumor-assoziierte VTE: womit wie lange antikoagulieren

Oral rivaroxaban versus standard therapy for the acute and continued treatment of symptomatic deep vein thrombosis. The EINSTEIN DVT study.

The current ACCP guidelines fail clinicians and patients - Against

New areas of development for the direct oral anticoagulants

Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Incidence of DVT Post- Hip or Knee Replacement. A Comparison of Incidence at Boundary Trails Health Centre to a Credible Baseline Incidence

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY

THROMBOTIC DISORDERS: The Final Frontier

New Developments in VTE Treatment

Measurement and Improvement of Quality of Cardiovascular Care DR : DEHESTANI

Preventing Blood Clots in Adult Patients

Deep Vein Thrombosis

Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients

Perioperative VTE Prophylaxis

THROMBOPROPHYLAXIS IN ELECTIVE FOOT AND ANKLE SURGERY

Updates in Medical Management of Pulmonary Embolism and Deep Vein Thrombosis. By: Justin Youtsey, Elliott Reiff, William Montgomery, Grant Finlan

Venous Thromboembolism. Prevention

How long to continue anticoagulation after DVT?

NICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1

Misunderstandings of Venous thromboembolism prophylaxis

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC

None. Who uses IV antibiotics before simple knee arthroscopies? 3/9/2018. Anticoagulants or Antibiotics Are they Necessary for Simple Knee Scopes?

Are there still any valid indications for thrombophilia screening in DVT?

Comparison of Venothromboembolism Prophylaxis Practices in a Winnipeg Tertiary Care Hospital to Chest Guidelines: A Quality Improvement Project

Individualizing VTE Treatment and Prevention of Recurrence: The Place for Direct Oral Anticoagulants in VTE

Drug Class Review Newer Oral Anticoagulant Drugs

Is Oral Rivaroxaban Safe and Effective in the Treatment of Patients with Symptomatic DVT?

What You Should Know

Thrombophilia. Stephan Moll, MD Medicine, Heme-Coag UNC Chapel Hill, NC. GASCO Atlanta Sept 8 th, Disclosures. Conflicts of interest: NONE

Medical Patients: A Population at Risk

Aspirin as Venous Thromboprophylaxis

Menopausal Hormone Therapy & Haemostasis

Prophylaxie primaire sur le patient ambulatoire. Marc Carrier

Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range

Anticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis

Cancer and blood clots

Diagnosis and management of heritable thrombophilias

Disclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach.

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

UPDATE ON TREATMENT OF ACUTE VENOUS THROMBOSIS

Daiichi Sankyo s Once-Daily Lixiana

Duration of Anticoagulant Therapy. Linda R. Kelly PharmD, PhC, CACP September 17, 2016

Transcription:

Update on the risk of DVT during air travel - does the economy class syndrome really exist? Thomas HW Stadlbauer Department of Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University of Munich

Disclosure Speaker name: Thomas Stadlbauer I have the following potential conflicts of interest to report: Study-Investigator: Lecturer: Travel grant: Bayer Bayer, Daiichi Sankyo, Bristol Myer Squibb, Pfizer Bristol Myers Squibb, Pfizer, Daiichi Sankyo xxx

Does the economy class syndrome really exist? or What do we know about travel-associated venous thromboembolism? Eminent based medicine Evidence level 2c Uptodate: Menaka Pai, MD, FRCPC, James D Douketis, MD, FRCPC, FACP, FCCP Prevention of venous thromboembolism in adult travelers, Clarke MJ, Broderick C, Hopewell S, Juszczak E, Eisinga A, Compression stockings for preventing deep vein thrombosis in airline passengers, Cochrane Database Syst Rev. 2016 Sep 14

Evidence level 2c Grade 2 recommendation is a weak recommendation. It means "this is our suggestion, but you may want to think about it." It is unlikely that you should follow the suggested approach in all your patients, and you might reasonably choose an alternative approach. Grade C means the evidence comes from observational studies, unsystematic clinical experience, or from randomized, controlled trials with serious flaws. Any estimate of effect is uncertain.

Does the economy class syndrome really exist? or What do we know about travel-associated venous thromboembolism? Agenda: 1. Economy class Syndrom 2. Definition 3. Epidemiology 4. Risk factors 5. Selecting a method of prevention (if necessary) 6. Practical recommendations

Most prominent victim of travel-associated venous thromboembolism

Most prominent victim of travel-associated venous thromboembolism President Nixon (1969-1974) VTE in 1964 Episode of phlebitis in left leg during a trip to Japan in 1965 VTE in 1973 during extended travel to Europe, Middle East and the Soviet Union

Travel reality for the majority Department of Vascular and Endovascular Surgery

1993 2000: Charles de Gaulle Airport, Paris => PE hospital n = 170 / 135.290.000 PE = 114 /170

Definition? PE Symptomatic DVT Asymptomatic DVT Calf DVT Calf muscular venous thrombosis Thrombophlebitis

Epidemiology Long-distance travel confers a small increased risk of VTE. The rates are higher in those who travel for prolonged periods and is greatest in the first two weeks after travel. The estimated risk of VTE conferred by prolonged travel increased approximately two- to fourfold. The incidence of VTE in travelers is low with higher rates reported when both asymptomatic and symptomatic VTE are included. Incidence for symptomatic VTE 1:4500 up to 1:6000.

Risk Factors => => Recent major surgery (including hip or knee arthroplasty within six weeks) Prior VTE (including travel-associated VTE) Active malignancy Pregnancy Advanced age Use of estrogen-containing oral contraceptives or other estrogen preparations Obesity Hereditary thrombophilia Immobility and window seating The presence of two or more risk factors for VTE (eg, oral contraceptive use plus factor V Leiden mutation) Female gender

Risk Factors Statement: The majority of individuals with travel-associated venous thromboembolism (VTE) have one or more known risk factors for thrombosis travel-related vs. personal-related is not known to have a higher incidence while travelling coach class Therefore the name economy class syndrome is misleading =>

Method of prevention General Measurements => keep on moving Graduated compression stocking, below the knee, dynamic, class I Pharmacological Interventions => Test theory

Test theory 1. HR: 0.84 (0.6 to 1,18) P<0.001, 5500 Pts., for noninferiority 2. US calf: sensitivity und specificity 70% 3. Incidence symptomatic VTE 1:6000 Study design n>10 6

Method of prevention General Measurements => keep on moving Graduated compression stocking, below to knee, dynamic, class I Pharmacological interventions (individual decision, no positive interventional studies): Aspirin (no evidence) Low molecular weight heparin (analogous to VTE prophylaxis) Factor Xa Inhibition (reality in actuality)

Take Home Messages I: Economy class syndrome is misleading => Definition is uncertain => mostly located at the calf Long-distance travel confers a small increased risk of VTE Most frequent manifestation is an isolated calf muscle vein thrombosis a finding with questionable clinical significance Incidence of symptomatic VTE is low (1:6000)

Take Home Messages II: Thromboprophylaxis is not necessary for most travelers Majority of individuals with travel-associated venous thromboembolism (VTE) have one or more known risk factors for thrombosis previous VTE Malignancy Below the knee compression stockings can be recommended (Grade 2c) Pharmacologic thromboprophylaxis is not routinely indicated, it is an option for patients at particularly high risk for VTE who consider a potential decrease in travel-associated VTE to outweigh the small increased risk of bleeding

NN Department of Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University of Munich